Trial data show oral weight loss pill helped patients shed up to 12% of body weight

A clinical trial of an oral weight loss pill found that participants lost up to 12% of their body weight, according to reported data from the study. The findings add to a growing body of evidence on pill-based alternatives to injectable obesity treatments and suggest oral medications may play a larger role in weight management.

Trial findings

Researchers reported that the oral medication produced weight loss results comparable to some injectable therapies currently on the market. Participants in the study experienced reductions in body weight over the course of the trial, with the highest responders achieving the 12% figure cited in the results.

The study adds to a broader debate about how oral drugs stack up against established options, including newer injectable medications. For context, a separate analysis reported that a high-protein diet was linked to faster weight loss than GLP-1 injections, highlighting the range of approaches under investigation.

Why an oral option matters

Weight management specialists have long pointed out that some patients are reluctant to use injectable drugs, whether due to needle anxiety, cost, or limited access. A pill-based treatment could lower those barriers and expand the pool of people willing to begin medical weight loss therapy.

Adults over 50, in particular, may benefit from treatments that do not require injections, and nutrition experts have highlighted other age-specific strategies that pair well with medical therapy. Some patients have already seen meaningful change, as in the case of a 68-year-old who lost three stone after her doctor raised concerns about her weight.

What comes next

Key questions remain before the pill reaches wide clinical use:

• How the drug performs in larger and more diverse trial populations.
• Its side-effect profile compared with injectable GLP-1 medications.
• Long-term weight maintenance after the treatment period ends.
• Regulatory review timelines and potential pricing once approved.

For now, the trial data point to an expanding toolkit for clinicians treating obesity, with oral medications joining diet, lifestyle change, and injectable drugs as possible options for patients seeking to lose weight.